OT welcomes George W. Sledge Jr., MD, to the Editorial Board as Chairman. Sledge is currently Professor of Medicine and Chief of the Division of Oncology at Stanford University where he focuses on the study and treatment of breast cancer. He has expertise in the development of targeted therapies, breast cancer murine models of growth and metastasis, and breast cancer genomics.
Prior to joining Stanford in 2013, Sledge served at the Indiana University for nearly 30 years (OT 11/10/12 issue), most recently as the Ballve-Lantero Professor of Medicine and Co-Leader of the Breast Cancer Program at IU's Simon Cancer Center. Sledge has also previously served as Chair of the Breast Committee of the Eastern Cooperative Oncology Group (ECOG) from 2002 to 2010; and he has previously served as President of the American Society of Clinical Oncology for the 2010-2011 term. He has also served on the Department of Defense Breast Cancer Research Program's Integration Panel, and as a member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee (ODAC).
Sledge has received numerous honors and awards, including: the Susan G. Komen Breast Cancer Foundation Komen Brinker Award for Scientific Distinction (2006); the Breast Cancer Foundation's Jill Rose Award (2007); the San Antonio Breast Cancer Symposium William L. McGuire Award (2010); the HOPE Funds for Cancer Research 2013 Award of Excellence for Medicine; and the Director's Service Award from the National Cancer Institute. He has also published numerous articles in medical journals and has chaired several clinical trials of new breast cancer treatments.
Sledge is a longtime contributor to OT; his popular column, "Musings of a Cancer Doctor," has been recognized with an APEX Award for Publication Excellence and a FOLIO: Eddie Honorable Mention award. Read his most recent postings on his OT blog at bit.ly/OT-Sledge. He has also written several "Best of the Year" research reviews for OT, including "2015: The Year in Breast Cancer" in this issue (see cover story).